AG Wilson, 25 attorneys general urge Biden administration to provide Medicare coverage for Alzheimer’s treatment
COLUMBIA, S.C. (WOLO)– South Carolina Attorney General Alan Wilson and 25 other attorneys general are calling on the Centers for Medicare and Medicaid Services (CMS) to provide Medicare coverage for a FDA-approved Alzheimer’s treatment.
In a press release by the Office of Attorney General Alan Wilson the attorney general says, “This is a bipartisan effort because approving this drug is a win-win. It helps patients, but it also saves taxpayers money by reducing the costs to Medicare of treating Alzheimer’s.”
The treatment specified in the letter is FDA-approved monoclonal antibodies (mAbs) directed against amyloid to help Alzheimer’s patient, say officials.
The drug has been proven to delay the progression of Alzheimer’s Disease, according to the press release.
Currently, CMS will only cover mAbs when it is administered through clinical trials or other studies.
The full letter can be read here.
